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Background
SIV studies reveal dramatic, systemic destruction of CD4+
T-cells in acute disease; this, and early levels of central
memory (TCM) subsets predict progression to death inde-
pendently of viral load. Similar data are not available for
HIV, because samples from early disease are rare and long,
untreated follow-up is usually not possible. We analyzed
a large cohort of confirmed seroconverters to test whether
T-cell and viral dynamics in early disease predict long-
term progression.
Methods
Samples from 466 untreated, early infection individuals
(median = 225 days), with substantial follow-up (median
= 4 years), were studied using two 13-color flow cytometry
panels, including: A) CD45RO, CD27, CD28, CCR5,
CCR7, CD127, CD57, and Ki-67 (unstimulated) and B)
IFNγ, IL2, TNFα, CD154, CD107a, CD45RO, CD27,
CCR7, and CD57 (after stimulation with HIV antigens).
We also measured cell-associated viral load (CAVL) in var-
ious CD4+ T-cell subsets. We correlated T-cell subset rep-
resentation, CAVL, and the magnitude, quality, and
phenotype of HIV-specific T cells with disease progres-
sion.
Results
TCM levels at the earliest HIV+ visit did not predict long-
term outcome. However, the following were associated
with slow progression: high levels of long-lived cells
(naive or CD127+ memory CD8), low Ki-67 expression,
and low CAVL during the first 7.5 months. Notably, CAVL
was present in naive cells. Also, no single T-cell function
(e.g. IFNγ) had predictive value; however, rapid progres-
sors (AIDS < 4.6 years) had "higher" levels of polyfunc-
tional CD4+ T-cells in early disease than AIDS-free
subjects. Finally, cytokine responses to Gag and Env dif-
fered dramatically.
Conclusion
These results suggest: 1) early depletion of precursor cells,
mediated by proliferation/differentiation, is a poor prog-
nostic factor independent of antigen load, 2) Ki-67 meas-
urements can inform early treatment decisions, and 3) the
quality of the T-cell response to HIV early in disease
impacts long-term progression. These data inform experi-
mental design in vaccine trials that test efficacy after
breakthrough infections.
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